Routine vs selective invasive strategies in patients with acute coronary syndromes: A collaborative meta-analysis of randomized trials

JAMA

Volumn 293, Issue 23, 2005, Pages 2908-2917

  Mehta, Shamir R ^a,b   Cannon, Christopher P ^c   Fox, Keith A A ^d   Wallentin, Lars ^e   Boden, William E ^f   Spacek, Rudolf ^g   Widimsky, Petr ^g   McCullough, Peter A ^h   Hunt, David ⁱ   Braunwald, Eugene ^c   Yusuf, Salim ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f HARTFORD HOSPITAL   (United States)

^g CHARLES UNIVERSITY   (Czech Republic)

^h WILLIAM BEAUMONT HOSPITAL   (United States)

ⁱ ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; DALTEPARIN; ENOXAPARIN; HEPARIN; TIROFIBAN; FIBRINOLYTIC AGENT;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DEATH; FOLLOW UP; HAZARD ASSESSMENT; HEART CATHETERIZATION; HEART INFARCTION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIC HEART DISEASE; META ANALYSIS; METHODOLOGY; MORTALITY; OUTCOMES RESEARCH; PATIENT; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; REVIEW; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; HEART MUSCLE REVASCULARIZATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS;

EID: 20444497400     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.293.23.2908     Document Type: Review

References (39)

1. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106: 1893-1900.
2. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without ST elevation. Lancet. 1998;352:507-514.
3. Bhatt DL, Roe MT, Peterson ED, et al; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-2104.
4. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes: variations in practice and outcome: findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002;23:1177-1189.
5. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in highrisk patients. BMJ. 2002;324:71-86.
6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
9. Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. Am J Cardiol. 1978;42:839-848.
10. Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris: results of a Veterans Administration Cooperative Study. N Engl J Med. 1987;316:977-984.
11. Scott SM, Deupree RH, Sharma GV, Luchie RJ. VA study of unstable angina: 10-year results show duration of surgical advantage for patients with impaired ejection fraction. Circulation. 1994;90:II120-II123.
12. Brown CA, Hutter AM, DeSanctis RW, et al. Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: results of in-hospital and chronic mortality and morbidity. Am Heart J. 1981;102:959-964.
13. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation. 1997;96:748-755.
14. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ. 1991;302:555-560.
15. Michalis LK, Stroumbis CS, Pappas K, et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery: invasive vs conservative surgery (TRACS study). Eur Heart J. 2000;21:1954-1959.
16. TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation. 1994;89:1545-1556.
17. McCullough PA, O'Neill WW, Graham M, et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. J Am Coll Cardiol. 1998;32:596-605.
18. Boden WE, O'Rourke RA, Crawford MH, et al; Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998;338:1785-1792.
19. FRagmin and Fast Revascularisation during In-Stability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354:708-715.
20. Cannon CP, Weintraub WS, Demopoulos LA, et al; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
21. Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. Eur Heart J. 2002;23:230-238.
22. Fox KA, Poole-Wilson PA, Henderson RA, et al; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-STelevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet. 2002;360:743-751.
23. Diderholm E, Andren B, Frostfeldt G, et al; Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am Heart J. 2002;143:760-767.
24. Morrow DA, Cannon CP, Rifai N, et al; TACTICSTIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286:2405-2412.
25. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593-1599.
26. de Winter RJ. Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Investigators. Presented at: the European Society of Cardiology Congress; August 29, 2004; Munich, Germany.
27. Van de Werf F, Gore JM, Avezum A, et al. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ. January 24, 2005 epub ahead of print.
28. CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
29. Mehta SR, Yusuf S, Peters RJ, et al; Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCICURE study. Lancet. 2001;358:527-533.
30. Steinhubl SR, Berger PB, Mann JT 3rd, et al; CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
31. Yusuf S, Mehta SR, Zhao F, et al; Clopidogrel in Unstable angina to prevent Recurrent Events Trial (CURE) Investigators. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003;107:966-972.
32. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436-443.
33. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 1998;338:1488-1497.
34. SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292:45-54.
35. Blazing MA, de Lemos JA, White HD, et al; A to Z Investigators. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.
36. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB 3rd. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997;95:2479-2484.
37. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a noninvasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000;356:9-16.
38. Lagerqvist B, Husted S, Kontny F, et al. A longterm perspective on the protective effects of an early invasive strategy in unstable coronary artery disease - a 2 year follow-up of the FRISC II invasive study. J Am Coll Cardiol. 2002;40:1902-1914.
39. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists' Collaboration. Lancet. 1994;344:563-570.